Q3 2019 Holdings
Filed 2019-11-12 | 19 holdings | $22.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $21.7M | 1,887,332 | 98.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $81.1K | 2,316,447 | 0.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $35.9K | 3,566,912 | 0.2% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $31.9K | 1,750,665 | 0.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $31.1K | 895,000 | 0.1% |
| Translate BIO Inc | COM | 89374L104 | $21.6K | 2,182,789 | 0.1% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $17.8K | 2,061,758 | 0.1% |
| Allena Pharmaceuticals Inc(ALNAEUR) | COM | 018119107 | $13.1K | 3,330,373 | 0.1% |
| Aptinyx Inc | COM | 03836N103 | $11.1K | 3,190,079 | 0.1% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $10.2K | 2,571,450 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $9.9K | 1,396,615 | 0.0% |
| Iterum Therapeutics PLC | SHS | G6333L101 | $8.9K | 1,538,316 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $8.5K | 4,256,526 | 0.0% |
| Entasis Therapeutics Hldgs I | COM | 293614103 | $8.0K | 1,349,953 | 0.0% |
| Sierra Oncology Inc | COM | 82640U107 | $3.2K | 8,112,121 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $2.6K | 1,312,258 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $1.5K | 467,743 | 0.0% |
| Bellicum Pharmaceuticals Inc | COM | 079481107 | $1.1K | 1,051,441 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $647 | 282,649 | 0.0% |